Skip to main content
Elsevier
Shopping Cart
openUserAccount

Biochemical Engineering Journal

  • ISSN: 1369-703X

Next planned ship date: December 15, 2023

  • 5 Year impact factor: 4
  • Impact factor: 3.9

Biochemical Engineering Journal welcomes submissions from NIH-funded authors. We deposit gold open access articles immediately in PubMed Central. For other articles, we shall… Read more

Image - Biochemical Engineering Journal
Subscription options

Subscription options

Next planned ship date:
December 15, 2023

Institutional subscription on ScienceDirect

Request a sales quote
Biochemical Engineering Journal welcomes submissions from NIH-funded authors. We deposit gold open access articles immediately in PubMed Central. For other articles, we shall deposit the accepted manuscript on behalf of the author to PubMed Central after 12 months (the normal embargo period for this journal is 24 months). For more information, please see here. The Biochemical Engineering Journal aims to promote progress in the crucial chemical engineering aspects of the development of biological processes associated with everything from raw materials preparation to product recovery relevant to industries as diverse as medical/healthcare, industrial biotechnology, and environmental biotechnology. The Journal welcomes full length original research papers, short communications, and review papers* in the following research fields: Biocatalysis (enzyme or microbial) and biotransformations, including immobilized biocatalyst preparation and kinetics Biosensors and Biodevices including biofabrication and novel fuel cell development Bioseparations including scale-up and protein refolding/renaturation Environmental Bioengineering including bioconversion, bioremediation, and microbial fuel cells Bioreactor Systems including characterization, optimization and scale-up Bioresources and Biorefinery Engineering including biomass conversion, biofuels, bioenergy, and optimization Industrial Biotechnology including specialty chemicals, platform chemicals and neutraceuticals Biomaterials and Tissue Engineering including bioartificial organs, cell encapsulation, and controlled release Cell Culture Engineering (plant, animal or insect cells) including viral vectors, monoclonal antibodies, recombinant proteins, vaccines, and secondary metabolites Cell Therapies and Stem Cells including pluripotent, mesenchymal and hematopoietic stem cells; immunotherapies; tissue-specific differentiation; and cryopreservation Metabolic Engineering, Systems and Synthetic Biology including OMICS, bioinformatics, in silico biology, and metabolic flux analysis Protein Engineering including enzyme engineering and directed evolution *Authors are requested to complete a Review Proposal Form for Editorial approval prior to submission of the review article. Proposals can be submitted to [email protected] or one of the Editors.